Bristol-Myers Squibb (BMY) News Today $55.84 +0.06 (+0.10%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$55.98 +0.14 (+0.25%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period 3 Precision Medicine Stocks That Could Transform HealthcareFebruary 21 at 2:27 PM | stocknews.comBristol-Myers Squibb (BMY) Gets a Hold from BernsteinFebruary 21 at 12:55 PM | markets.businessinsider.comWilliam Blair Issues Pessimistic Estimate for BMY EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Equities research analysts at William Blair decreased their Q1 2026 earnings per share estimates for Bristol-Myers Squibb in a note issued to investors on Wednesday, February 19th. William Blair analyst M. Phipps now expects that the biopharmaceuticFebruary 21 at 9:03 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by VisionPoint Advisory Group LLCVisionPoint Advisory Group LLC grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 30.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,677 shares of the biopharmacFebruary 21 at 7:31 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Capital Advisory Group Advisory Services LLCCapital Advisory Group Advisory Services LLC increased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 86.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,121 shares of the biopharmaceutical compFebruary 21 at 7:31 AM | marketbeat.comBristol-Myers Squibb Q4 Earnings TranscriptFebruary 21 at 7:15 AM | marketbeat.comParadigm Asset Management Co. LLC Has $2.23 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)Paradigm Asset Management Co. LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 39,408 shares of the biopharmaceutical company's stock after buying an additional 6,400 shares during thFebruary 21 at 6:54 AM | marketbeat.comArdent Capital Management Inc. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Ardent Capital Management Inc. decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 39.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,700 shares of the biopharmaceutical company'sFebruary 21 at 5:53 AM | marketbeat.comBristol-Myers Squibb: Balancing Growth and Challenges Amidst Market Dynamics – A Hold RecommendationFebruary 21 at 5:21 AM | tipranks.comING Groep NV Has $26.42 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)ING Groep NV cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 54.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 467,030 shares of the biopharmaceutical company's stock after selling 567,623 shares during the period. ING GrFebruary 21 at 5:18 AM | marketbeat.comIeq Capital LLC Grows Position in Bristol-Myers Squibb (NYSE:BMY)Ieq Capital LLC grew its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 40.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 135,161 shares of the biopharmaceutical company's stock after acquirFebruary 21 at 4:44 AM | marketbeat.comBristol-Myers Squibb (BMY) Receives a Buy from Truist FinancialFebruary 20 at 3:53 PM | markets.businessinsider.comBristol-Myers Squibb: Promising Growth Amidst Legacy Challenges and Policy HeadwindsFebruary 20 at 8:00 AM | tipranks.comFirst Bank & Trust Boosts Stock Position in Bristol-Myers Squibb (NYSE:BMY)First Bank & Trust boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 49.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,268 shares of the biopharmaceutical company's stFebruary 20 at 6:26 AM | marketbeat.com8,104 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Advyzon Investment Management LLCAdvyzon Investment Management LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 8,104 shares of the biopharmaceutical company's stoFebruary 20 at 6:17 AM | marketbeat.comHandelsbanken Fonder AB Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)Handelsbanken Fonder AB lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,477,571 shares of the biopharmaceutical companFebruary 20 at 6:07 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) EVP Samit Hirawat Purchases 1,823 SharesFebruary 20 at 5:25 AM | insidertrades.comBryn Mawr Capital Management LLC Acquires 115,245 Shares of Bristol-Myers Squibb (NYSE:BMY)Bryn Mawr Capital Management LLC lifted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1,584.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 122,517 shares of the biopharmaceutical company's stock afteFebruary 20 at 5:05 AM | marketbeat.comBioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closingFebruary 20 at 1:01 AM | prnewswire.comInsider Buying: Bristol-Myers Squibb (NYSE:BMY) EVP Purchases 1,823 Shares of StockBristol-Myers Squibb (NYSE:BMY - Get Free Report) EVP Samit Hirawat acquired 1,823 shares of the business's stock in a transaction on Friday, February 14th. The stock was bought at an average cost of $54.84 per share, for a total transaction of $99,973.32. Following the completion of the transaction, the executive vice president now directly owns 63,932 shares of the company's stock, valued at $3,506,030.88. This trade represents a 2.94 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.February 19 at 8:34 PM | marketbeat.comBristol Myers announces OS from Phase 3 CheckMate -816 studyFebruary 19 at 1:09 PM | markets.businessinsider.comGood Life Advisors LLC Has $3.77 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Good Life Advisors LLC boosted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 106.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,721 shares of the biopharmaceutical company's stock aftFebruary 19 at 7:40 AM | marketbeat.comBristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung CancerFebruary 19 at 6:59 AM | businesswire.comConvergence Investment Partners LLC Buys 6,888 Shares of Bristol-Myers Squibb (NYSE:BMY)Convergence Investment Partners LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,493 shares of the biopharmaceutical companFebruary 19 at 6:09 AM | marketbeat.comNew York State Common Retirement Fund Has $143.74 Million Stake in Bristol-Myers Squibb (NYSE:BMY)New York State Common Retirement Fund reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,541,436 shares of the biopharmaceutical company's stocFebruary 19 at 5:40 AM | marketbeat.comAtria Wealth Solutions Inc. Has $10.79 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Atria Wealth Solutions Inc. lifted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 190,678 shares of the biopharmaceutical company's stock afFebruary 19 at 5:14 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 0.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,443,854 shares of the biopharFebruary 19 at 4:39 AM | marketbeat.comValley Wealth Managers Inc. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Valley Wealth Managers Inc. trimmed its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 62,931 shares of the biopharmaceutical company's stock after selling 7,824 shares during the pFebruary 18, 2025 | marketbeat.comBraun Stacey Associates Inc. Invests $19.71 Million in Bristol-Myers Squibb (NYSE:BMY)Braun Stacey Associates Inc. acquired a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 348,518 shares of the biopharmaceutical company's stock, valued at approximately $19,71February 18, 2025 | marketbeat.comKornitzer Capital Management Inc. KS Buys 15,130 Shares of Bristol-Myers Squibb (NYSE:BMY)Kornitzer Capital Management Inc. KS raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 306,517 shares of the biopharmaceutical company's stock after purchasing aFebruary 18, 2025 | marketbeat.comGAM Holding AG Sells 39,363 Shares of Bristol-Myers Squibb (NYSE:BMY)GAM Holding AG reduced its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 202,646 shares of the biopharmaceutical company's stock after selling 39,363 shareFebruary 18, 2025 | marketbeat.comD.A. Davidson & CO. Purchases 7,343 Shares of Bristol-Myers Squibb (NYSE:BMY)D.A. Davidson & CO. lifted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 386,277 shares of the biopharmaceutical company's stock after acquiriFebruary 18, 2025 | marketbeat.comCitizens & Northern Corp Acquires 5,026 Shares of Bristol-Myers Squibb (NYSE:BMY)Citizens & Northern Corp grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 35.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,120 shares of the biopharmaceutical company's stocFebruary 18, 2025 | marketbeat.comTruist Financial Corp Raises Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Truist Financial Corp increased its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,597,150 shares of the biopharmaceuticalFebruary 18, 2025 | marketbeat.comCIBC Asset Management Inc Purchases 12,702 Shares of Bristol-Myers Squibb (NYSE:BMY)CIBC Asset Management Inc lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 381,648 shares of the biopharmaceutical company'February 18, 2025 | marketbeat.comSanctuary Advisors LLC Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)Sanctuary Advisors LLC boosted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 343,064 shares of the biopharmaceutical company's stock after purchasing an additional 22,388February 18, 2025 | marketbeat.comAllworth Financial LP Raises Holdings in Bristol-Myers Squibb (NYSE:BMY)Allworth Financial LP increased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 23.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 77,835 shares of the biopharmaceutical company's stock after purchasing an additional 14,624 shares during theFebruary 18, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Principal Securities Inc.Principal Securities Inc. raised its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,800 shares of the biopharmaceutical company's stockFebruary 18, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 194,445 shares of the biopharmaceutical cFebruary 18, 2025 | marketbeat.comBristol Myers announces new five-year results from POETYK PSO trialFebruary 17, 2025 | markets.businessinsider.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Partners Capital Investment Group LLPPartners Capital Investment Group LLP lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 48.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,770 shares of the biopharmaceuticalFebruary 17, 2025 | marketbeat.comKLCM Advisors Inc. Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY)KLCM Advisors Inc. lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 532,539 shares of the biopharmaceutical company's stock after sellinFebruary 17, 2025 | marketbeat.comAlphaCentric Advisors LLC Makes New $1.11 Million Investment in Bristol-Myers Squibb (NYSE:BMY)AlphaCentric Advisors LLC bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 19,649 shares of the biopharmaceutical company's stock, valued at approximately $1,111February 17, 2025 | marketbeat.comAmericana Partners LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)Americana Partners LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 213,637 shares of the biopharmaceutical company's stock, valued at approximately $February 17, 2025 | marketbeat.comStrategic Financial Concepts LLC Acquires Shares of 77,383 Bristol-Myers Squibb (NYSE:BMY)Strategic Financial Concepts LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 77,383 shares of the biopharmaceutical company's stock, valued at aFebruary 17, 2025 | marketbeat.comBristol-Myers Squibb Co (BMY) Announces Positive Five-Year Results for Sotyktu in Psoriasis ...February 17, 2025 | gurufocus.comBristol-Myers Squibb Co (BMY) Announces Positive Five-Year Results for Sotyktu in Psoriasis ...February 17, 2025 | gurufocus.comBristol Myers reports no new safety signals observed in five-year Sotyktu dataFebruary 16, 2025 | markets.businessinsider.comMy “Two-Step” Plan for Surviving Shaky Markets – and Coming Out AheadFebruary 16, 2025 | investorplace.comNew Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates ...February 16, 2025 | gurufocus.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.480.60▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼6330▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMY Stock Alerts